MARKET

NUWE

NUWE

Nuwellis Inc
NASDAQ
0.2523
-0.0222
-8.09%
After Hours: 0.2400 -0.0123 -4.88% 18:40 05/10 EDT
OPEN
0.2837
PREV CLOSE
0.2745
HIGH
0.2840
LOW
0.2356
VOLUME
3.33M
TURNOVER
0
52 WEEK HIGH
5.73
52 WEEK LOW
0.1250
MARKET CAP
3.84M
P/E (TTM)
-0.0304
1D
5D
1M
3M
1Y
5Y
NUWELLIS ANNOUNCES PURCHASE AGREEMENT WITH A 50 HOSPITAL NETWORK FOR AQUADEX ULTRAFILTRATION THERAPY
Reuters · 1d ago
3 Penny Stocks to Watch Now!
TipRanks · 1d ago
Maxim Group Sticks to Its Hold Rating for Nuwellis (NUWE)
TipRanks · 1d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Repare Therapeutics (NASDAQ:RPTX) shares rose 34.1% to $4.4 during Wednesday's pre-market session. The company's, Q1 earnings came out yesterday. CEL-SCI stock increased by 13.1%. Myriad Genetics and Envoy Medical also moved upwards.
Benzinga · 2d ago
Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings
U.S. Stocks traded mixed on Tuesday, with the Nasdaq Composite falling around 0.2%. The Dow traded up 0.01% to 38,857.00 while the NASDAQ fell 0.20%. Great Lakes Dredge & Dock Corporation shares jumped 24% on Tuesday following better-than-expected first-quarter results. Asian markets closed mixed; European shares were higher today.
Benzinga · 3d ago
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Beyond, Inc. Shares dipped 20.8% to $17.34 on Tuesday. The company posted weaker-than-expected quarterly results. Beyond posted adjusted loss of $1.22 per share, versus estimates for a loss of 87 cents per share. Golden Sun Health Technology Group Limited shares gained 94.7% in today's mid-day session.
Benzinga · 3d ago
NUWE Stock Earnings: Nuwellis Beats EPS, Misses Revenue for Q1 2024
Nuwellis reported earnings per share of -60 cents for the first quarter of 2024. The company reported revenue of $1.86 million. This was 12.41% worse than the analyst estimate for revenue. Nuwellis also reported results for the fourth quarter of 2015.
Investorplace · 3d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Nuwellis (NASDAQ:NUWE) shares rose 57.7% to $0.27 during Tuesday's regular session. The company's, Q1 earnings report came out today. Bioventus stock moved upwards by 28.87% and Design Therapeutics stock rose 28.49%.
Benzinga · 3d ago
More
About NUWE
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Webull offers Nuwellis Inc stock information, including NASDAQ: NUWE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUWE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NUWE stock methods without spending real money on the virtual paper trading platform.